Arcellx, Inc. (ACLX)

114.27 +0.22 (+0.19%) USD  |  NASDAQ  |  Mar 04, 11:57
More

Arcellx Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Eli Lilly & Co. Upgrade
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade